Delivery Order SPE2DB22D6029-SPE2DB25FLVUT
- Not listed
- The Defense Logistics Agency awarded a $14,360 firm fixed price delivery order to Amerisourcebergen Drug Corporation for levofloxacin tablets. Under this contract, Amerisourcebergen will supply 50-count bottles of the 250mg antibiotic tablets to locations in Conshohocken, Pennsylvania by September 11, 2023 in support of the Department of Defense's medical supply needs. As a top 10 Defense Logistics Agency supplier, Amerisourcebergen regularly fulfills pharmaceutical delivery orders under the...
- This delivery order against an unspecified government-wide acquisition contract awards Amerisourcebergen Drug Corporation $77 to supply 750 mg/150 ml vials of the antibiotic levofloxacin in 150 ml saline bags to the Defense Logistics Agency. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to the agency's location in Conshohocken, Pennsylvania by the completion date of September 28, 2023. The firm fixed price contract was awarded...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $34,883.25 to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Leqvio 284 mg/1.5 mL syringes. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Moxifloxacin 400 mg/250 mL bags. This competitively awarded, non-set-aside delivery order has a ceiling value of $1,495.80 with a firm fixed price and is scheduled for completion by July 24, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for moxifloxacin HCl 400 mg tablets (unit dose, 50s) with a ceiling value of $1,380.00. This competitive, non-set-aside contract was awarded on July 31, 2025, with a completion date of August 1, 2025. The order will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, under firm fixed-price terms as a delivery order, indicating this is a fulfillment against an...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Likmez 500 mg/5 mL suspension in a 200 mL quantity. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,298.44 and an ultimate completion date of August 6, 2025. The contract utilizes no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $4,282.08 on August 14, 2025, for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packages of 50 units. This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania....
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packaging of 50 units. The contract is valued at $1,752.82 with a firm fixed price structure and an ultimate completion date of August 8, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packaging of 50s. This is a firm fixed price delivery order with a ceiling value of $1,852.51 and an ultimate completion date of August 18, 2025. The award was competitively awarded with no set-aside designation, and performance will be executed from the vendor's corporate office in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packs of 50, with a ceiling value of $1,188.33. This is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB25FLVUTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Levofloxacin 25 mg/ml Solution in 480 ml quantities, with a ceiling value of $3,960.98 and an ultimate completion date of September 2, 2025. This is a firm fixed price delivery order with no set-aside designation, executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement within AmerisourceBergen's extensive portfolio of federal medical supply contracts with the Defense Logistics Agency. Levofloxacin is a fluoroquinolone antibiotic commonly used in military and federal healthcare systems for treating bacterial infections. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications, vaccines, and medical devices to support military healthcare programs and other government healthcare systems worldwide. The company has demonstrated consistent capability to meet federal procurement requirements through open competition, with delivery orders typically executed on a firm fixed price basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 8/29/25 |